Search Results

You searched for : cardiometabolic  

Menopause Care in India: Building Awareness Beyond Reproductive Years

This article explains menopause care in india through a practical Medicircle lens. It examines the main decisions, responsibilities, safeguards and review measures that can help ...
Nov 04

Adolescent Healthcare in India: Why Teens Need a Different Model

India's 253 million adolescents need a dedicated healthcare model addressing their unique nutritional, mental, and reproductive health needs beyond what pediatric or adult systems ...
Oct 30

Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)

Bringing glucose, lifestyle and vital health data together through AI-powered insights and a connected health ecosystem....
Sep 15

India's Next Public Health Challenge: Chronic Disease in Younger Adults

Chronic diseases like diabetes, hypertension, and heart disease are increasingly affecting young Indians in their 20s and 30s, driven by lifestyle changes, stress, and genetic ...
Sep 02

Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily Meals

Discover evidence-based heart-healthy eating patterns that support cardiovascular wellness through plant-forward proteins, whole grains, healthy fats, reduced sodium, and practical food swaps. ...
Aug 07

Heart-Healthy Dietary Patterns: Clinical Nutrition into Daily Meals

Modern cardiovascular nutrition has shifted away from restrictive, nutrient-focused rules toward balanced, evidence-based dietary patterns that support overall heart health. Current research emphasizes ...
Jun 15

Can Ice Cream Really Lower Diabetes Risk: Why Some Studies Keep Reporting a Result That Makes No Sense

Unexpected findings can open new lines of inquiry. The history of nutrition research is filled with examples where anomalies eventually led to deeper understanding....
Mar 13

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (8.9 kg ;9.2%) compared to 11.0 lbs (5 ...
Feb 28

Agilus Diagnostics Launches India’s Most Comprehensive Vital Shape Test Suite for Obesity and Metabolic Health

Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare Ltd., today announced the launch of the Complete Care ...
Dec 04

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 ...
Oct 31

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 16

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 15

Lilly's oral GLP-1, Orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) ...
Aug 28

HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025

HighTide Therapeutics, a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases....
Apr 25

Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA

...
Apr 15

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)....
Sep 11

How a Fiber-Rich Diet and Gut Parasites Can Improve Your Health

The findings of this study open new avenues for exploring how the gut microbiome, including organisms like Blastocystis, influences our health....
Jul 16

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress

Berberine Ursodeoxycholate (HTD1801) Provides a Unique Therapeutic Approach for Patients with Metabolic Liver Disease and Severe Insulin Resistance...
Jun 05

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs

here is a clear demand for a mid-sized, agile and responsive CRO with an in-house regulatory affairs team and a proven track record ...
Jun 04

Hypertension’s Effect on Diabetes and Heart Failure - Medicircle

Learn ways to deal with high blood tension, especially for people with hypertension in their families. Hypertension can lead to heart failure. But by implementing ...
May 16

Coffee may reduce risk of death from stroke and heart disease

The latest research on coffee suggests the results are not the same for normal and decaff coffee...
Aug 28

Could BeatO beat India's diabetes risk?

After their latest funding round in which BeatO successfully received Rs 42 crores, BeatO plans to increase its subscriber base. Will the diabetic care management ...
Aug 20

Low glycaemic diet shows meaningful improvements for people with diabetes

Benefits may go beyond what can be achieved with drugs or insulin alone ...
Aug 11

Green Mediterranean (‘green Med’) diet may be even better for health

Contains more plant matter plus green tea and Mankai (duckweed) than traditional version ...
Nov 25

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

...
Nov 19

25 Matching result(s) found!

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026